Advent Life Sciences LLP updates holding in Als Iii Member Co Limited

Als Iii Member Co Limited is a London based fund management firm incorporated in 2018. The company provides portfolio management services alongside the management of mutual and pension funds.

Advent Life Sciences LLP has updated its position on the cap table of the London firm. The latest confirmation statement for the period ending 4 June 2026 indicates an administrative update to the company share register. Advent Life Sciences LLP is now recorded as the holder of 1 Ordinary share. This entry replaces a previous listing for Advent Life Sciences LLP which included the specific address of 158-160 North Gower Street in the shareholder name field.

The total share capital of the company remains unchanged at 1 Ordinary share. Advent Life Sciences LLP has been the sole shareholder on the cap table throughout the period. This entity is an established venture capital firm within the healthcare space. According to Companies House records, Advent Life Sciences LLP also holds shareholdings in Fiera Oncology Limited, Aviadobio Ltd, and Amphista Therapeutics Limited.

The filing confirms the continued ownership structure of the London firm as it enters its eighth year of operation. The update to the register ensures the shareholder name is listed without the previous address details while maintaining the same single share holding. This change ensures the public record is consistent with the current registration of the primary investor.